MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 28 filers reported holding MILESTONE PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,165,531 | +28.8% | 126,826 | -13.8% | 0.10% | +57.8% |
| Q2 2022 | $905,065 | -4.2% | 147,165 | 0.0% | 0.06% | -12.3% |
| Q1 2022 | $944,799 | -2.0% | 147,165 | 0.0% | 0.07% | +17.7% |
| Q4 2021 | $963,931 | +48.6% | 147,165 | +29.6% | 0.06% | +37.8% |
| Q3 2021 | $648,639 | – | 113,597 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alta Fundamental Advisers LLC | 1,176,189 | $3,646,186 | 1.74% |
| Bleichroeder LP | 1,326,085 | $4,110,864 | 1.01% |
| BML Capital Management, LLC | 272,500 | $844,750 | 0.78% |
| VR Adviser, LLC | 2,208,812 | $6,847,317 | 0.72% |
| Lion Point Capital, LP | 450,207 | $1,395,642 | 0.62% |
| PVG ASSET MANAGEMENT CORP | 15,405 | $47,755 | 0.32% |
| Affinity Asset Advisors, LLC | 335,068 | $1,038,711 | 0.29% |
| RTW INVESTMENTS, LP | 3,256,102 | $10,093,916 | 0.21% |
| Ikarian Capital, LLC | 462,828 | $1,434,767 | 0.17% |
| Boxer Capital, LLC | 309,007 | $957,922 | 0.05% |